Navigation Links
007762 Medication Nebulizer Kit

Products007762 Medication Nebulizer Kit
Company Portex
Item 007762 Medication Nebulizer Kit
Features 
  • Designed for medication delivery in the 1.0 to 5.0 µ range
  • Angled medication cup for quick and efficient delivery of medication at angles up to 45°
  • Fits-All® oxygen tubing connectors eliminates the need for nipple adapters, speeding delivery
  • Latex free
  • Oxygen Tubing with Fits-All® Connector
  • Adult Aerosol Mask
  • 50 units per case
Description Portex® medication nebulizers offer a spill-proof design and effective output, even when tilted up to a 45° angle. All medical nebulizers are free-standing for easy preparation.

A wide variety of configurations are available.

All Portex® medication nebulizer products are latex-free.

Portex® medication nebulizers feature consistently fine misting and the efficient use of nebulized medication.
Info Portex
Customer Service: (603) 352-3812
Web site: http://www.smiths-medical.com

Related medicine products :

1. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Adult Kits
2. 007761 Medication Nebulizer Kit
3. 007763 Medication Nebulizer Kit
4. 007764 Medication Nebulizer Kit
5. 007769 Medication Nebulizer Kit
6. Raindrop® Medication Nebulizer - Adult Aerosol Mask & Tubing
7. Raindrop® Medication Nebulizer - Mouthpiece, Tee Adapter, Reservoir & Tubing
8. Raindrop® Medication Nebulizer - Universal Tip, Tubing, Mouthpiece, Tee Adapter & Reservoir
9. Raindrop® Medication Nebulizer - Tee Adapter, Mouthpiece & Reservoir
10. Raindrop® Medication Nebulizer - Tee Adapter & Mouthpiece
11. 002174 Small Volume Medication Kits
...y for the total eye. Whether used as part of a pre...ate a specific scanning technique, the multi-frequ...zing the image resolution. Solid tip transducer fo...ion techniques. Unique knurled barrel provides eas...
PremierEdge™ Stab Knives - 15°.
The Answer to Micro-Incision Cataract Surgery (MICS) Is PremierEdge&traede; Technology With its unique double-step hexagonal shape, the PE3915 microsurgical knife is ideal for MICS. The consistently
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula.
Medicine Products:
(Date:8/29/2008)...http://www.aronowitzmd.com [Los Angeles cosmetic ...ence in plastic surgery procedures for post bariat...ay be necessary for these patients, health and wel...d specialty of procedures for after weight loss. ...August 29, 2008 -- Bariatric surgery improves the ...
(Date:8/28/2008)...r conventional therapy, study found , , ...on a treadmill improves brain function and fitness...rough the usual rehabilitation program, a new stud...ents have," said study researcher Dr. Andreas Luft...ilitation at the University of Zurich in Switzerla...
(Date:8/28/2008)...ical efforts of the Maryland Medicaid contract, H...ational medical,management firm, appointed Lenaye ...ctor. Dr. Lawyer will oversee all clinical aspects... Hunt Valley, Maryland Harrisburg,office., "Dr. L...aryland," said,Alice Stollenwerk Petrulis, MD, FAC...
(Date:8/28/2008)...and physical, especially for the impaired, study s...s) -- A new study says that 13 percent of American... abuse. , The University of Chicago researcher...t), being taken advantage of financially (3.5 perc...lso found that seniors with physical impairments w...
Breaking Medicine News(10 mins):Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:13% of Seniors Report Being Mistreated 2
...standing the mechanisms underlying embryo developm...ve work between biologists specialized in the stu...scientists specialized in the design of mathematic... of biological systems. Specifically, a study of ...
...ied a "master switch" for the production of brown ...and counters obesity caused by overeating , by con...n of Dana-Farber Cancer Institute believes that tu... switch in humans may be a new strategy for treati...
...as unearthed the relationship between high blood p... of circumstances , including among individuals wi...ntreal Heart Institute, currently affiliated with ...t this phenomenon extends to people who typically ...
...known as incretin-based therapy, which act via cer...rovide modest effectiveness and favorable weight ...es and may represent an alternative to other hypog...or type 2 diabetes are often limited by adverse ef...
Other Medicine News:Health News:Understanding the Mechanism Underlying Embryo Development 2Health News:Understanding the Mechanism Underlying Embryo Development 3Health News:Scientists Identify "master Switch" for Brown Fat in Mice 2Health News:Alternative Option for Type2 Diabetes Treatment 2
(Date:8/27/2008)... - Patients in the VELCADE, melphalan and predni...efit as well as a 30 percent complete response -, ...ium: The Takeda,Oncology Company today announced t...ndomized, Phase III VISTA(1) trial in this week,s ...e results showed a significant survival,benefit an...
(Date:8/27/2008)... Nationally Recognized Pediatric Heart Center at T...ccess for Community to Complete Range of Care and ...wly Recruited Pediatric Cardiology Team Treats Eve...-USNewswire/ -- The Children,s Hospital at,Montefi...atric heart,transplantation to the Bronx, followin...
(Date:8/26/2008)... Company to present data from landmark SYNT...wire-FirstCall/ -- Boston Scientific,Corporation (...ompany,s major,events and press announcements at t...hich runs from August 30 to September 3 in Munich,... data from the SYNTAX trial,which compares percut...
(Date:8/26/2008)... Study finds most patients can drive safely six...l., Aug. 26 /PRNewswire-USNewswire/ -- Six weeks f...s are so low that they are able to,get back behind...e August,2008 issue of The Journal of Bone and Joi...t emergency brake time response in patients who un...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Braking After Bunion Surgery 2Braking After Bunion Surgery 3ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 6963 1ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 6963 2ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 6963 3Ben Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia 25022 1Ben Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia 25022 2Ortho Biotech Announces Nationwide Voluntary Recall of Procrit 28R 29 28Epoetin Alfa 29 Lot Number P114942A 6962 1Ortho Biotech Announces Nationwide Voluntary Recall of Procrit 28R 29 28Epoetin Alfa 29 Lot Number P114942A 6962 2Replidyne Announces Second Quarter 2008 Results From Operations 6959 1Replidyne Announces Second Quarter 2008 Results From Operations 6959 2Replidyne Announces Second Quarter 2008 Results From Operations 6959 3Replidyne Announces Second Quarter 2008 Results From Operations 6959 4Replidyne Announces Second Quarter 2008 Results From Operations 6959 5Replidyne Announces Second Quarter 2008 Results From Operations 6959 6Replidyne Announces Second Quarter 2008 Results From Operations 6959 7
...M, N.C.--(BUSINESS WIRE)--May 8, 2007 - Inspire,Ph... results of a,Phase 2 dose-ranging clinical trial ...tients with seasonal allergic rhinitis. For,the pr...om score,dose-related effects were observed in th...tistical superiority over placebo., Christy L. Sha...
...axin Phase 2 BPD Clinical Data Selected and Presen...Chrysalis Aerosol-Generator Technology,Demonstrate...ay 8, 2007 (PRIME NEWSWIRE) -- Discovery,Laborator...m its,previously completed Phase 2 clinical trial ...on) for the prevention and,treatment of Bronchopul...
Other Medicine Technology:Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis 2Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis 3Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis 4Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 2Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 3Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 4Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 5Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 6Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 7